Interferon β-1b retinopathy during a treatment for multiple sclerosis

被引：0
|
作者：
Sommer, S [1 ]
Sablon, JC [1 ]
Zaoui, M [1 ]
Rozot, P [1 ]
Hosni, A [1 ]
机构：
[1] CHR ND Bonsecours, F-57038 Metz 1, France
来源：
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2001年 / 24卷 / 05期
关键词：
interferon; multiple sclerosis; cotton wool spots; retinopathy;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Ocular adverse effects of interferon are described during the treatment of malignant diseases and chronic viral hepatitis with interferon alpha. At this time, there is no report of these effects during multiple sclerosis treatment with interferon beta -1b. The authors report a bilateral retinopathy during this treatment. The production of neutralizing antibodies during interferon beta -1b treatment leads to a decreese in diminution of therapeutic efficacy. When treatment failure occurs, neutralizing antibodies are to be tested.
引用
收藏
页码：509 / 512
页数：4
相关论文
共 50 条
  • [21] Immunomodulatory effects of interferon-β-1b in patients with multiple sclerosis
    Ossege, LM
    Sindern, E
    Patzold, T
    Malin, JP
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (06) : 1085 - 1100
  • [22] Interferon-β-1b A Review of its Use in Multiple Sclerosis
    Plosker, Greg L.
    CNS DRUGS, 2011, 25 (01) : 67 - 88
  • [23] Early benefit of interferon β-1b in neuropsychiatric abnormalities in multiple sclerosis
    Sirbu, CA
    Constantin, D
    Tirca, A
    Popa, N
    Ocneanu, A
    Munteanu, R
    Chirtes, A
    Nitulescu, R
    Cristea, E
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S229 - S230
  • [24] Apolipoprotein Alleles and the Response to Interferon-β-1b in Multiple Sclerosis
    Carmona, Olga
    Masuet, Cristina
    Alia, Pedro
    Moral, Ester
    Alonso-Magdalena, Lucia
    Casado, Virginia
    Martin-Ozaeta, Gisela
    Arbizu, Txomin
    EUROPEAN NEUROLOGY, 2011, 65 (03) : 132 - 137
  • [25] Arthritis during interferon beta-1b treatment in multiple sclerosis
    Altintas, A
    Alici, Y
    Melikoglu, M
    Siva, A
    MULTIPLE SCLEROSIS, 2002, 8 (06): : 534 - 536
  • [26] Comparison of interferon β-1a subcutaneous and interferon β-1b on medication adherence in patients with multiple sclerosis
    Joyeux, A.
    Meletiche, D.
    Kozma, C.
    Dickson, M.
    Bennett, R.
    JOURNAL OF NEUROLOGY, 2009, 256 : S162 - S163
  • [27] Biosimilar of interferon-beta 1b in the treatment of multiple sclerosis and the own experience in the use of ronbetal
    Khabirov, F. A.
    Babicheva, N. N.
    Khaibullin, T. I.
    Averyanova, L. A.
    Granatov, E. V.
    Akhmedova, G. M.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2012, 112 (09) : 113 - 122
  • [28] Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-β-1b: A case report
    Sahraian M.A.
    Moghadasi A.N.
    Owji M.
    Maboudi M.
    Kosari F.
    McGee J.C.
    Minagar A.
    Journal of Medical Case Reports, 7 (1)
  • [29] Successful Long-Term Treatment of Relapsing-Remitting Multiple Sclerosis with Interferon β-1b
    Schmidt, S.
    AKTUELLE NEUROLOGIE, 2012, 39 : S22 - S23
  • [30] Interferon-β1b in Multiple Sclerosis: Effect on Progression of Disability and Clinical Markers of Treatment Response
    Carmona, Olga
    Casado, Virginia
    Moral, Ester
    Alonso-Magdalena, Lucia
    Martinez-Yelamos, Antonio
    Martinez-Yelamos, Sergio
    Martin-Ozaeta, Gisela
    Arbizu, Txomin
    EUROPEAN NEUROLOGY, 2008, 60 (06) : 279 - 284
12345